Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 230 blog entries.

MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK)

MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) Drug alert number: EL (24)A/60 Date issued: 3 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) DMRC reference number: DMRC-31179592 Company name: [...]

The post MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK) appeared first on Community Pharmacy England.

By |December 3rd, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Phenoxymethylpenicillin 250mg/5ml Oral Solution Sugar Free (Kent Pharma UK)

MHRA Class 4 Medicines Defect Information: Tramadol Hydrochloride 50 mg capsules & Tramadol Hydrochloride Morningside 50 mg Prolonged-Release capsules (Morningside Healthcare Ltd)

MHRA Class 4 Medicines Defect Information: Tramadol Hydrochloride 50 mg capsules & Tramadol Hydrochloride Morningside 50 mg Prolonged-Release capsules (Morningside Healthcare Ltd) Drug alert number: EL (24)A/57 Date issued: 27 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Tramadol Hydrochloride 50 mg capsules [...]

The post MHRA Class 4 Medicines Defect Information: Tramadol Hydrochloride 50 mg capsules & Tramadol Hydrochloride Morningside 50 mg Prolonged-Release capsules (Morningside Healthcare Ltd) appeared first on Community Pharmacy England.

By |November 27th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Tramadol Hydrochloride 50 mg capsules & Tramadol Hydrochloride Morningside 50 mg Prolonged-Release capsules (Morningside Healthcare Ltd)

Funding & Reimbursement Shorts: Dispensing and Claiming SSPs

Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video providing guidance on how to correctly endorse and claim for any supplies made against a Serious Shortage Protocol (SSP). This is part of Community Pharmacy England’s ‘Funding & Reimbursement Shorts’ series, which has been created to provide pharmacy owners and their [...]

The post Funding & Reimbursement Shorts: Dispensing and Claiming SSPs appeared first on Community Pharmacy England.

By |November 15th, 2024|Lexpos News|Comments Off on Funding & Reimbursement Shorts: Dispensing and Claiming SSPs

Expiry of SSP074 Monomax® XL 60mg tablets

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Monomax® XL 60mg tablets is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP074 Monomax® XL 60mg tablets expires at 23.59pm on Friday 15 November 2024. After this date, any prescriptions for Monomax® XL 60mg tablets [...]

The post Expiry of SSP074 Monomax® XL 60mg tablets appeared first on Community Pharmacy England.

By |November 15th, 2024|Lexpos News|Comments Off on Expiry of SSP074 Monomax® XL 60mg tablets

MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd)

MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) Drug alert number: EL (24)A/54 Date issued: 12 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole 40mg Powder for solution for infusion. Company name: Viatris [...]

The post MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd) appeared first on Community Pharmacy England.

By |November 12th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Omeprazole 40mg Powder for solution for infusion (Viatris UK Healthcare Ltd)